Pronađeno: 1-4 / 4 radova

Autori: Mercadal Santiago

>> Filter: Samo Article i Review

>> Sve godine

Naslov Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article)
Autori Davies Andrew Merli Francesco Mihaljevic Biljana S  Mercadal Santiago Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude Genevray Magali Zharkov Artem Dixon Mark Brewster Michael Barrett Martin MacDonald David 
Info LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282
Projekat F Hoffmann-La Roche
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract)
Autori Davies Andrew J Mihaljevic Biljana S  Mercadal Santiago Mihaylov Georgi Leppa Sirpa Cotting Denise Veenstra Klaas Zharkov Artem Dixon Mark Barrett Martin Macdonald David 
Info BLOOD, (2016), vol. 128 br. 22, str. -
Projekat Takeda Pharmaceutical Company Ltd; Mundipharma; GSKGlaxoSmithKline; Karyopharma; Roche Holding; Gilead Sciences; Bayer AG; Pfizer; JanssenJohnson & Johnson USAJanssen Biotech Inc; Mundipharma; CTI Bio Pharma
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Comparison of Subcutaneous and Intravenous Rituximab in the Maintenance Setting: Updated Safety Results of the Phase III Sabrina Study in Patients with Follicular Lymphoma (Meeting Abstract)
Autori Davies A Mihaljevic Biljana S  Mercadal Santiago Mihaylov G Leppa S Cotting D Munoz FJ Veenstra K Berthillon N Barrett M MacDonald D 
Info HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 1, str. 271-272
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Subcutaneous Rituximab and Chemotherapy Achieves Similar Overall Response Rates to Intravenous Rituximab in First-Line Follicular Lymphoma: Efficacy and Safety Results of the Phase Iii Sabrina Study (Meeting Abstract)
Autori Davies A Merli Francesco Mihaljevic Biljana S  Mercadal Santiago Solal-Celigny Philippe Boehnke Axel Berge Claude Cambon N Macgregor L Brewster M Barrett M MacDonald D 
Info HAEMATOLOGICA, (2014), vol. 99 br. , Suppl. 1, str. 225-225
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX